{"database": "lobbying", "table": "lobbying_activities", "rows": [[3375839, "4fff56ad-83fc-4791-97dd-562ed3eee966", "Q2", "ELITE STRATEGIC SERVICES", 401108852, "CONSERVATIVES FOR PROPERTY RIGHTS", 2025, "second_quarter", "LBR", "H.R. 384 (One Agency Act) S. 1040 (Drug Competition Enhancement Act) S. 1096 (Preserve Access to Affordable Generics and Biosimilars Act)", "HOUSE OF REPRESENTATIVES,SENATE", 0, 0, "2025-07-01T15:00:20-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3375839"], "units": {}, "query_ms": 5.83525700494647, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}